Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.910
-0.010 (-0.52%)
Aug 10, 2026, 9:30 AM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 189.66 million as of August 10, 2026. Its market cap has increased by 9.17% in one year.
Market Cap
189.66M
Enterprise Value
204.85M
Revenue
117.33M
Ranking
n/a
PE Ratio
17.46
Stock Price
1.91
ChartMarket Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 189.66M, a decrease of -10.37%. That is a compound annual growth rate of -1.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 189.66M | 14.75% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Auxly Cannabis Group | 288.78M |
| Aurora Cannabis | 257.06M |
| Cardiol Therapeutics | 229.39M |
| TerrAscend | 225.98M |
| Organigram Global | 192.86M |
| BioSyent | 171.57M |
| Medexus Pharmaceuticals | 160.20M |
| Grown Rogue International | 149.96M |